The determinants of tumour immunogenicity

Thomas Blankenstein, Pierre G. Coulie, Eli Gilboa, Elizabeth M. Jaffee

Research output: Contribution to journalReview article

Abstract

Many standard and targeted therapies, as well as radiotherapy, have been shown to induce an anti-tumour immune response, and immunotherapies rely on modulating the host immune system to induce an anti-tumour immune response. However, the immune response to such therapies is often reliant on the immunogenicity of a tumour. Tumour immunogenicity varies greatly between cancers of the same type in different individuals and between different types of cancer. So, what do we know about tumour immunogenicity and how might we therapeutically improve tumour immunogenicity? We asked four leading cancer immunologists around the world for their opinions on this important issue.

Original languageEnglish (US)
Pages (from-to)307-313
Number of pages7
JournalNature Reviews Cancer
Volume12
Issue number4
DOIs
StatePublished - Apr 1 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The determinants of tumour immunogenicity'. Together they form a unique fingerprint.

  • Cite this